Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why AbbVie Stock Jumped Today


Shares of AbbVie (NYSE: ABBV) climbed on Monday after the pharmaceutical giant struck a deal to acquire clinical-stage biotech Apogee Therapeutics (NASDAQ: APGE) for $10.9 billion.

Image source: The Motley Fool.

Under the terms of the deal, AbbVie would purchase Apogee for $135.11 per share in cash. That's a 49% premium over the stock's closing price on Thursday, the last trading day before the deal's announcement.

Continue reading


Source Fool.com

AbbVie Inc. Stock

€218.10
1.020%
There is an upward development for AbbVie Inc. compared to yesterday, with an increase of €2.20 (1.020%).
With 45 Buy predictions and not a single Sell prediction AbbVie Inc. is an absolute favorite of our community.
With a target price of 230 € there is a slightly positive potential of 5.46% for AbbVie Inc. compared to the current price of 218.1 €.
Like: 0
Share

Comments